Haemophilus Influenzae Type B Vaccine Market, Global Outlook and Forecast 2022-2028

Publisher Name :
Date: 27-Feb-2022
No. of pages: 77

Haemophilus influenzae b is the leading cause of death and morbidity in children, and its six entities are meningitis, bacterial pneumonia, epiglottitis, septicaemia, cellulitis and bone and joint infections.HIB disease is the cause of about 90 percent of child deaths each year.HIB vaccines are effective and safe for infants because they contain polyribonitol phosphate that binds to proteins in response to meningitis and pneumonia in children.

This report contains market size and forecasts of Haemophilus Influenzae Type B Vaccine in global, including the following market information:

Global Haemophilus Influenzae Type B Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Haemophilus Influenzae Type B Vaccine Market Sales, 2017-2022, 2023-2028, (M Doses)

Global top five Haemophilus Influenzae Type B Vaccine companies in 2021 (%)

The global Haemophilus Influenzae Type B Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Liquid Monovalent HIB Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Haemophilus Influenzae Type B Vaccine include Novartis, Merck, Sanofi, GlaxoSmithKline, Takeda Pharmaceuticals Company, Walvax Biotechnology, Lanzhou Institute of Biologica and Immunize BC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Haemophilus Influenzae Type B Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Haemophilus Influenzae Type B Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Haemophilus Influenzae Type B Vaccine Market Segment Percentages, by Type, 2021 (%)

- Liquid Monovalent HIB

- Liquid Combination HIB

- Lyophilized Monovalent HIB

- Lyophilized Combination HIB

Global Haemophilus Influenzae Type B Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Haemophilus Influenzae Type B Vaccine Market Segment Percentages, by Application, 2021 (%)

- Hospital

- Research Institutions

- Pharmaceutical and Biotechnology Companies

- Academic Institutions

- Other

Global Haemophilus Influenzae Type B Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Doses)

Global Haemophilus Influenzae Type B Vaccine Market Segment Percentages, By Region and Country, 2021 (%)

- North America

- - US

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Rest of Asia

- South America

- - Brazil

- - Argentina

- - Rest of South America

- Middle East & Africa

- - Turkey

- - Israel

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Haemophilus Influenzae Type B Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Haemophilus Influenzae Type B Vaccine revenues share in global market, 2021 (%)

Key companies Haemophilus Influenzae Type B Vaccine sales in global market, 2017-2022 (Estimated), (M Doses)

Key companies Haemophilus Influenzae Type B Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Novartis

- Merck

- Sanofi

- GlaxoSmithKline

- Takeda Pharmaceuticals Company

- Walvax Biotechnology

- Lanzhou Institute of Biologica

- Immunize BC

Haemophilus Influenzae Type B Vaccine Market, Global Outlook and Forecast 2022-2028

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Haemophilus Influenzae Type B Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Haemophilus Influenzae Type B Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Haemophilus Influenzae Type B Vaccine Overall Market Size
2.1 Global Haemophilus Influenzae Type B Vaccine Market Size: 2021 VS 2028
2.2 Global Haemophilus Influenzae Type B Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Haemophilus Influenzae Type B Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Haemophilus Influenzae Type B Vaccine Players in Global Market
3.2 Top Global Haemophilus Influenzae Type B Vaccine Companies Ranked by Revenue
3.3 Global Haemophilus Influenzae Type B Vaccine Revenue by Companies
3.4 Global Haemophilus Influenzae Type B Vaccine Sales by Companies
3.5 Global Haemophilus Influenzae Type B Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Haemophilus Influenzae Type B Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Haemophilus Influenzae Type B Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Haemophilus Influenzae Type B Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Haemophilus Influenzae Type B Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Haemophilus Influenzae Type B Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Haemophilus Influenzae Type B Vaccine Market Size Markets, 2021 & 2028
4.1.2 Liquid Monovalent HIB
4.1.3 Liquid Combination HIB
4.1.4 Lyophilized Monovalent HIB
4.1.5 Lyophilized Combination HIB
4.2 By Type - Global Haemophilus Influenzae Type B Vaccine Revenue & Forecasts
4.2.1 By Type - Global Haemophilus Influenzae Type B Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Haemophilus Influenzae Type B Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Haemophilus Influenzae Type B Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Haemophilus Influenzae Type B Vaccine Sales & Forecasts
4.3.1 By Type - Global Haemophilus Influenzae Type B Vaccine Sales, 2017-2022
4.3.2 By Type - Global Haemophilus Influenzae Type B Vaccine Sales, 2023-2028
4.3.3 By Type - Global Haemophilus Influenzae Type B Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Haemophilus Influenzae Type B Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Haemophilus Influenzae Type B Vaccine Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Research Institutions
5.1.4 Pharmaceutical and Biotechnology Companies
5.1.5 Academic Institutions
5.1.6 Other
5.2 By Application - Global Haemophilus Influenzae Type B Vaccine Revenue & Forecasts
5.2.1 By Application - Global Haemophilus Influenzae Type B Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Haemophilus Influenzae Type B Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Haemophilus Influenzae Type B Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Haemophilus Influenzae Type B Vaccine Sales & Forecasts
5.3.1 By Application - Global Haemophilus Influenzae Type B Vaccine Sales, 2017-2022
5.3.2 By Application - Global Haemophilus Influenzae Type B Vaccine Sales, 2023-2028
5.3.3 By Application - Global Haemophilus Influenzae Type B Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Haemophilus Influenzae Type B Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Haemophilus Influenzae Type B Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Haemophilus Influenzae Type B Vaccine Revenue & Forecasts
6.2.1 By Region - Global Haemophilus Influenzae Type B Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Haemophilus Influenzae Type B Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Haemophilus Influenzae Type B Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Haemophilus Influenzae Type B Vaccine Sales & Forecasts
6.3.1 By Region - Global Haemophilus Influenzae Type B Vaccine Sales, 2017-2022
6.3.2 By Region - Global Haemophilus Influenzae Type B Vaccine Sales, 2023-2028
6.3.3 By Region - Global Haemophilus Influenzae Type B Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Haemophilus Influenzae Type B Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Haemophilus Influenzae Type B Vaccine Sales, 2017-2028
6.4.3 US Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.4.4 Canada Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.4.5 Mexico Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Haemophilus Influenzae Type B Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Haemophilus Influenzae Type B Vaccine Sales, 2017-2028
6.5.3 Germany Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.5.4 France Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.5.5 U.K. Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.5.6 Italy Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.5.7 Russia Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.5.9 Benelux Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Haemophilus Influenzae Type B Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Haemophilus Influenzae Type B Vaccine Sales, 2017-2028
6.6.3 China Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.6.4 Japan Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.6.5 South Korea Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.6.7 India Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Haemophilus Influenzae Type B Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Haemophilus Influenzae Type B Vaccine Sales, 2017-2028
6.7.3 Brazil Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.7.4 Argentina Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales, 2017-2028
6.8.3 Turkey Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.8.4 Israel Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
6.8.6 UAE Haemophilus Influenzae Type B Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Corporate Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Haemophilus Influenzae Type B Vaccine Major Product Offerings
7.1.4 Novartis Haemophilus Influenzae Type B Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 Novartis Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Haemophilus Influenzae Type B Vaccine Major Product Offerings
7.2.4 Merck Haemophilus Influenzae Type B Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Merck Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Major Product Offerings
7.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Sanofi Key News
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Corporate Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Major Product Offerings
7.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 GlaxoSmithKline Key News
7.5 Takeda Pharmaceuticals Company
7.5.1 Takeda Pharmaceuticals Company Corporate Summary
7.5.2 Takeda Pharmaceuticals Company Business Overview
7.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Major Product Offerings
7.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Takeda Pharmaceuticals Company Key News
7.6 Walvax Biotechnology
7.6.1 Walvax Biotechnology Corporate Summary
7.6.2 Walvax Biotechnology Business Overview
7.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Major Product Offerings
7.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Walvax Biotechnology Key News
7.7 Lanzhou Institute of Biologica
7.7.1 Lanzhou Institute of Biologica Corporate Summary
7.7.2 Lanzhou Institute of Biologica Business Overview
7.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Major Product Offerings
7.7.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 Lanzhou Institute of Biologica Key News
7.8 Immunize BC
7.8.1 Immunize BC Corporate Summary
7.8.2 Immunize BC Business Overview
7.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Major Product Offerings
7.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 Immunize BC Key News
8 Global Haemophilus Influenzae Type B Vaccine Production Capacity, Analysis
8.1 Global Haemophilus Influenzae Type B Vaccine Production Capacity, 2017-2028
8.2 Haemophilus Influenzae Type B Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Haemophilus Influenzae Type B Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Haemophilus Influenzae Type B Vaccine Supply Chain Analysis
10.1 Haemophilus Influenzae Type B Vaccine Industry Value Chain
10.2 Haemophilus Influenzae Type B Vaccine Upstream Market
10.3 Haemophilus Influenzae Type B Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Haemophilus Influenzae Type B Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Haemophilus Influenzae Type B Vaccine in Global Market
Table 2. Top Haemophilus Influenzae Type B Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Haemophilus Influenzae Type B Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Haemophilus Influenzae Type B Vaccine Sales by Companies, (M Doses), 2017-2022
Table 6. Global Haemophilus Influenzae Type B Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Haemophilus Influenzae Type B Vaccine Price (2017-2022) & (USD/Dose)
Table 8. Global Manufacturers Haemophilus Influenzae Type B Vaccine Product Type
Table 9. List of Global Tier 1 Haemophilus Influenzae Type B Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Haemophilus Influenzae Type B Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Haemophilus Influenzae Type B Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Haemophilus Influenzae Type B Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Haemophilus Influenzae Type B Vaccine Sales (M Doses), 2017-2022
Table 15. By Type - Global Haemophilus Influenzae Type B Vaccine Sales (M Doses), 2023-2028
Table 16. By Application - Global Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Haemophilus Influenzae Type B Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Haemophilus Influenzae Type B Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Haemophilus Influenzae Type B Vaccine Sales (M Doses), 2017-2022
Table 20. By Application - Global Haemophilus Influenzae Type B Vaccine Sales (M Doses), 2023-2028
Table 21. By Region - Global Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Haemophilus Influenzae Type B Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Haemophilus Influenzae Type B Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Haemophilus Influenzae Type B Vaccine Sales (M Doses), 2017-2022
Table 25. By Region - Global Haemophilus Influenzae Type B Vaccine Sales (M Doses), 2023-2028
Table 26. By Country - North America Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Haemophilus Influenzae Type B Vaccine Sales, (M Doses), 2017-2022
Table 29. By Country - North America Haemophilus Influenzae Type B Vaccine Sales, (M Doses), 2023-2028
Table 30. By Country - Europe Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Haemophilus Influenzae Type B Vaccine Sales, (M Doses), 2017-2022
Table 33. By Country - Europe Haemophilus Influenzae Type B Vaccine Sales, (M Doses), 2023-2028
Table 34. By Region - Asia Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Haemophilus Influenzae Type B Vaccine Sales, (M Doses), 2017-2022
Table 37. By Region - Asia Haemophilus Influenzae Type B Vaccine Sales, (M Doses), 2023-2028
Table 38. By Country - South America Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Haemophilus Influenzae Type B Vaccine Sales, (M Doses), 2017-2022
Table 41. By Country - South America Haemophilus Influenzae Type B Vaccine Sales, (M Doses), 2023-2028
Table 42. By Country - Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales, (M Doses), 2017-2022
Table 45. By Country - Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales, (M Doses), 2023-2028
Table 46. Novartis Corporate Summary
Table 47. Novartis Haemophilus Influenzae Type B Vaccine Product Offerings
Table 48. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 49. Merck Corporate Summary
Table 50. Merck Haemophilus Influenzae Type B Vaccine Product Offerings
Table 51. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 52. Sanofi Corporate Summary
Table 53. Sanofi Haemophilus Influenzae Type B Vaccine Product Offerings
Table 54. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 55. GlaxoSmithKline Corporate Summary
Table 56. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Offerings
Table 57. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 58. Takeda Pharmaceuticals Company Corporate Summary
Table 59. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Offerings
Table 60. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 61. Walvax Biotechnology Corporate Summary
Table 62. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Offerings
Table 63. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 64. Lanzhou Institute of Biologica Corporate Summary
Table 65. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Offerings
Table 66. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 67. Immunize BC Corporate Summary
Table 68. Immunize BC Haemophilus Influenzae Type B Vaccine Product Offerings
Table 69. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$, Mn) and Average Price (USD/Dose) (2017-2022)
Table 70. Haemophilus Influenzae Type B Vaccine Production Capacity (M Doses) of Key Manufacturers in Global Market, 2020-2022 (M Doses)
Table 71. Global Haemophilus Influenzae Type B Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Haemophilus Influenzae Type B Vaccine Production by Region, 2017-2022 (M Doses)
Table 73. Global Haemophilus Influenzae Type B Vaccine Production by Region, 2023-2028 (M Doses)
Table 74. Haemophilus Influenzae Type B Vaccine Market Opportunities & Trends in Global Market
Table 75. Haemophilus Influenzae Type B Vaccine Market Drivers in Global Market
Table 76. Haemophilus Influenzae Type B Vaccine Market Restraints in Global Market
Table 77. Haemophilus Influenzae Type B Vaccine Raw Materials
Table 78. Haemophilus Influenzae Type B Vaccine Raw Materials Suppliers in Global Market
Table 79. Typical Haemophilus Influenzae Type B Vaccine Downstream
Table 80. Haemophilus Influenzae Type B Vaccine Downstream Clients in Global Market
Table 81. Haemophilus Influenzae Type B Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Haemophilus Influenzae Type B Vaccine Segment by Type
Figure 2. Haemophilus Influenzae Type B Vaccine Segment by Application
Figure 3. Global Haemophilus Influenzae Type B Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Haemophilus Influenzae Type B Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Haemophilus Influenzae Type B Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Haemophilus Influenzae Type B Vaccine Sales in Global Market: 2017-2028 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Haemophilus Influenzae Type B Vaccine Revenue in 2021
Figure 9. By Type - Global Haemophilus Influenzae Type B Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Haemophilus Influenzae Type B Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Haemophilus Influenzae Type B Vaccine Price (USD/Dose), 2017-2028
Figure 12. By Application - Global Haemophilus Influenzae Type B Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Haemophilus Influenzae Type B Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Haemophilus Influenzae Type B Vaccine Price (USD/Dose), 2017-2028
Figure 15. By Region - Global Haemophilus Influenzae Type B Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Haemophilus Influenzae Type B Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Haemophilus Influenzae Type B Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Haemophilus Influenzae Type B Vaccine Sales Market Share, 2017-2028
Figure 19. US Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Haemophilus Influenzae Type B Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Haemophilus Influenzae Type B Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Haemophilus Influenzae Type B Vaccine Sales Market Share, 2017-2028
Figure 33. China Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Haemophilus Influenzae Type B Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Haemophilus Influenzae Type B Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Haemophilus Influenzae Type B Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Haemophilus Influenzae Type B Vaccine Production Capacity (M Doses), 2017-2028
Figure 49. The Percentage of Production Haemophilus Influenzae Type B Vaccine by Region, 2021 VS 2028
Figure 50. Haemophilus Influenzae Type B Vaccine Industry Value Chain
Figure 51. Marketing Channels
  • Global Cephalosporin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 109
    Cephalosporin is an antibiotic medication commonly prescribed to treat several different types of infections. Cephalosporin originally derived from The fungus Acremonium, which was previously known as "Cephalosporium". The global Cephalosporin market was valued at US$ 1380.7 million in 2023 and is anticipated to reach US$ 1346.9 million by 2030, witnessing a CAGR of -0.3% during The forecast period 2024-2030. Market competition is intense. Qilu Antibiotics, Nectar Lifes......
  • Global Polymixin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 120
    According to our LPI (LP Information) latest study, the global Polymixin market size was valued at US$ 229.9 million in 2023. With growing demand in downstream market, the Polymixin is forecast to a readjusted size of US$ 291 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Polymixin market. Polymixin are expected to show stable growth in the future market. However, product differentiation, reducing costs, and sup......
  • Global Sepsis Partnering Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The Sepsis Partnering market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Partnering market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape......
  • Global Cephalosporin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 156
    According to our LPI (LP Information) latest study, the global Cephalosporin market size was valued at US$ 1350.7 million in 2023. With growing demand in downstream market, the Cephalosporin is forecast to a readjusted size of US$ 1319.6 million by 2030 with a CAGR of -0.3% during review period. The research report highlights the growth potential of the global Cephalosporin market. Cephalosporin are expected to show stable growth in the future market. However, product differentiation, re......
  • Global Amoxicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 127
    According to our LPI (LP Information) latest study, the global Amoxicillin market size was valued at US$ 4512.7 million in 2023. With growing demand in downstream market, the Amoxicillin is forecast to a readjusted size of US$ 5711.7 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Amoxicillin market. Amoxicillin are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • Global Metronidazole Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 136
    According to our LPI (LP Information) latest study, the global Metronidazole market size was valued at US$ 110.5 million in 2023. With growing demand in downstream market, the Metronidazole is forecast to a readjusted size of US$ 106.6 million by 2030 with a CAGR of -0.5% during review period. The research report highlights the growth potential of the global Metronidazole market. Metronidazole are expected to show stable growth in the future market. However, product differentiation, redu......
  • Global Drugs for Herpes Labialis (Oral Herpes) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Drugs for Herpes Labialis (Oral Herpes) market size was valued at US$ 2404.5 million in 2023. With growing demand in downstream market, the Drugs for Herpes Labialis (Oral Herpes) is forecast to a readjusted size of US$ 3402.2 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drugs for Herpes Labialis (Oral Herpes) market. Drugs for Herpes Labialis (Ora......
  • Global Ampicillin Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Ampicillin market size was valued at US$ 161.6 million in 2023. With growing demand in downstream market, the Ampicillin is forecast to a readjusted size of US$ 194.7 million by 2030 with a CAGR of 2.7% during review period. The research report highlights the growth potential of the global Ampicillin market. Ampicillin are expected to show stable growth in the future market. However, product differentiation, reducing costs, a......
  • Global Acinetobacter Infections Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 101
    According to our LPI (LP Information) latest study, the global Acinetobacter Infections Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the Acinetobacter Infections Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Acinetobacter Infections Treatment market. Acinetobacter Infections Treatment are expected to show stable ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs